A Phase 4, Multicenter, Randomized, Double-Blinded, Controlled Study of OraVerse® for Safety and Efficacy in Pediatric Dental Patients Undergoing Mandibular and Maxillary Procedures First published 09/02/2016 Last updated 24/05/2024 EU PAS number:EUPAS11647 Study Finalised